Table 1 Safety evaluation on patients between response and no-response group
Measures (normal value range) | No-response | Response | ||
|---|---|---|---|---|
Before treatment | After treatment | Before treatment | After treatment | |
Total protein (65–85 g/L) | 73.24 ± 4.32 | 72.52 ± 3.46 | 72.63 ± 5.21 | 74.64 ± 3.68 |
Albumin (40–55 g/L) | 33.23 ± 5.31 | 32.57 ± 3.54 | 32.54 ± 4.63 | 40.63 ± 3.25* |
Globulin (20–40 g/L) | 30.62 ± 3.57 | 31.39 ± 4.36 | 31.58 ± 4.23 | 32.13 ± 3.86 |
Cholesterol (3.1–5.72 mmol/L) | 4.03 ± 1.34 | 4.23 ± 1.53 | 4.15 ± 1.26 | 4.28 ± 1.93 |
Triglyceride (0.30–1.7 mmol/L) | 1.46 ± 0.69 | 1.49 ± 0.83 | 1.51 ± 0.38 | 1.43 ± 0.58 |
Creatinine (41–73 μmol/L) | 46.53 ± 13.52 | 45.36 ± 12.38 | 43.36 ± 12.78 | 45.25 ± 14.21 |
Urea (2.6–7.5 mmol/L) | 4.23 ± 1.35 | 4.34 ± 1.28 | 4.12 ± 1.24 | 4.15 ± 1.87 |
Fasting blood glucose (3.9–6.1 mmol/L) | 4.74 ± 0.83 | 4.84 ± 0.96 | 4.67 ± 0.73 | 4.75 ± 0.86 |
White blood cell (3.5–9.5) × 109 | 5.65 ± 1.35 | 5.78 ± 1.26 | 5.84 ± 1.39 | 5.59 ± 1.47 |
Hemoglobin (115–150 g/L) | 102.35 ± 18.79 | 103.24 ± 19.21 | 101.15 ± 19.82 | 113.46 ± 16.62* |
Platelet (94–268) × 109 | 253.23 ± 68.31 | 262.31 ± 72.78 | 263.12 ± 70.24 | 223.19 ± 65.87* |